- ►annals.org [PDF] WT Thanassi, RT Schoen - Annals of internal medicine, 2000 - Am Coll Physicians In the past 20 years, remarkable strides have been made toward understanding and
preventing Lyme disease in humans. In December 1998, the US Food and Drug Ad-
ministration approved a recombinant outer surface pro- tein A vaccine ... Cited by 41 - Related articles - BL Direct - All 5 versions
H Lomholt, AM Lebech, K Hansen, F Brandrup, … - Acta dermato-venereologica, 2000 - dokumenthaandbog.dk The kinetics of antibodies to Borrelia burgdorferi following successful
treatment of early and late cutaneous borreliosis were analysed in consecutive
serum samples by an enzyme-linked immunosorbent assay (ELISA) technique. ... Cited by 16 - Related articles - View as HTML - BL Direct - All 10 versions
KP Hunfeld, P Kraiczy, E Kekoukh, V Schäfer, … - International journal of medical microbiology: IJMM, 2002 - ncbi.nlm.nih.gov Lyme disease represents a disorder of potentially chronic proportions, and
relatively little is known about the in vivo pharmacodynamic interactions of
antimicrobial agents with borreliae. So far, evidence-based drug regimens ... Cited by 17 - Related articles - All 2 versions
[CITATION] Therapy and prognosis. IN: Oschmann P et al: Lyme borreliosis and tick-borne encephalitis, …
P Oschmann, R Kaiser - Med Verlag AG (1999b), International Medical Publishers … Cited by 3 - Related articles
[CITATION] Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates, Intern
PG Manning - Iowa medicine: journal of the Iowa Medical Society, 1989 - ncbi.nlm.nih.gov 1: Iowa Med. 1989 Jun;79(6):277-80. Fulminant refractory Lyme disease.
Manning PG. Lyme Disease, which is carried by ticks, has ... Cited by 4 - Related articles
